http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014504638-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4745 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4745 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506 |
filingDate | 2012-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2014-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2014504638-A |
titleOfInvention | combination |
abstract | The present invention relates to methods for treating human breast cancer, as well as pharmaceutical combinations useful for such treatment. In particular, the method comprises 5-[[4-[(2,3-dimethyl-2H-indazol-6-yl) methylamino] -2-pyrimidinyl] amino] -2-methylbenzenesulfonamide or a pharmaceutically acceptable The salt thereof and (S) -10-[(dimethylamino) methyl] -4-ethyl-4,9-dihydroxy-1H-pyrano [3 ', 4': 6,7] indolidino [1,2- b] A method for treating breast cancer comprising the step of administering quinoline-3,14- (4H, 12H) -dione or a pharmaceutically acceptable salt thereof to a human in need thereof. [Selection] Figure 1 |
priorityDate | 2011-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 85.